Patent details
300193 Product Name: Bevacizumab
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300193
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP1325932
- Status:
- Expired Art. 14 (a) of the EC Regulations
- Application number:
- 300193
- Procedural language:
- Dutch
- First Applicant Residence Country:
- United States of America (US)
Paediatric Extension
- SPC Extension Filing Date:
- 18/04/2017
- SPC Extension Agent/Owner Name:
- Genentech, Inc. , ir. M.F.J.M. Ketelaars c.s.
- SPC Extension Status:
- Extension Granted
- SPC Extension Grant Date:
- 27/06/2017
- SPC Extension Request Refusal Date:
- SPC Extension Revocation Date:
Marketing Authorization
1
- Marketing Authorization Number:
- CH/56922/01
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 16/12/2004
- Marketing Authorization Country:
- Switzerland (CH)
2
- Marketing Authorization Number:
- CH/56922/02
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 16/12/2004
- Marketing Authorization Country:
- Switzerland (CH)
3
- Marketing Authorization Number:
- EU/1/04/300/002
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 12/01/2005
- Marketing Authorization Country:
- European Union (EU)
4
- Marketing Authorization Number:
- EU/1/04/300/001
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 12/01/2005
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 20/04/2005
- First Marketing Authorization date:
- 16/12/2004
- Grant date:
- 28/07/2005
- Activation date:
- 03/04/2018
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 20/04/2005
- SPC/SPC Extension Expiration Date:
- 15/06/2020
- Lapsed By Expiration Date:
- 16/06/2020
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 20/04/2005
- Name:
- Genentech, Inc.
- Address:
- 1 DNA Way, 94080-4990, South San Francisco, California, United States of America (US)
Agent
- Name:
- ir. M.F.J.M. Ketelaars c.s.
- From:
- 20/04/2005
- Address:
- NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 25/20
- Publication date:
- 17/06/2020
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 15/18
- Publication date:
- 04/04/2018
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 26/17
- Publication date:
- 28/06/2017
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
- Bulletin Heading:
- SPC
- Journal edition number:
- 17/17
- Publication date:
- 26/04/2017
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
- Bulletin Heading:
- SPC
- Journal edition number:
- 2005/10
- Publication date:
- 03/10/2005
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
6
- Bulletin Heading:
- SPC
- Journal edition number:
- 2005/07
- Publication date:
- 01/07/2005
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 07/11/2019
- Last Annual Fee Paid Number:
- 23
- Last Annual Fee Paid Amount:
- 2000 Euro
- Payer:
- NLO bvba
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 27/06/2017 | SPC Documents | Certificate SPC | 1 | /3/9/1/0/0/0400300193/docs/300193_1_supplprotectioncertificate20170628033330934.pdf | ||
| 27/06/2017 | Outgoing Correspondence | Outgoing Letter | 1 | /3/9/1/0/0/0400300193/docs/300193_15_outgoingcorrespondence20170628033330867.pdf | ||
| 24/04/2017 | Outgoing Correspondence | Confirmation receipt request for extension | 1 | /3/9/1/0/0/0400300193/docs/300193_8_134083l505.pdf | ||
| 19/04/2017 | SPC Documents | Marketing Authorization SPC | 5 | /3/9/1/0/0/0400300193/docs/300193_0_supplprotectioncertificate20170424015250326.pdf | ||
| 19/04/2017 | SPC Documents | Annex SPC | 18 | /3/9/1/0/0/0400300193/docs/300193_7_supplprotectioncertificate20210203050315664.pdf | ||
| 19/04/2017 | Incoming Correspondence Paper | Accompanying letter incoming document | 6 | /3/9/1/0/0/0400300193/docs/300193_10_incomingcorrespondencepaper20170424015250850.pdf | ||
| 19/04/2017 | SPC Documents | Annex SPC | 1 | /3/9/1/0/0/0400300193/docs/300193_13_supplprotectioncertificate20210203050454139.pdf | ||
| 19/04/2017 | SPC Documents | Annex SPC | 18 | /3/9/1/0/0/0400300193/docs/300193_16_supplprotectioncertificate20170424015250645.pdf | ||
| 19/04/2017 | SPC Documents | Annex SPC | 3 | /3/9/1/0/0/0400300193/docs/300193_17_supplprotectioncertificate20170424015250557.pdf | ||
| 19/04/2017 | Application Form | First filed application form | 2 | /3/9/1/0/0/0400300193/docs/300193_21_applicationform20170424015250046.pdf | ||
| 19/04/2017 | SPC Documents | Summary of the characteristics of the product | 51 | /3/9/1/0/0/0400300193/docs/300193_22_supplprotectioncertificate20170424015250443.pdf | ||
| 28/07/2005 | Outgoing Correspondence | Outgoing Letter | 1 | /3/9/1/0/0/0400300193/docs/300193_2_outgoingcorrespondence20050728.pdf | ||
| 28/07/2005 | SPC Documents | Certificate SPC | 1 | /3/9/1/0/0/0400300193/docs/300193_11_supplprotectioncertificate20210203045557248.pdf | ||
| 25/07/2005 | SPC Documents | Annex SPC | 2 | /3/9/1/0/0/0400300193/docs/300193_6_supplprotectioncertificate20210203044902226.pdf | ||
| 25/07/2005 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /3/9/1/0/0/0400300193/docs/300193_20_incomingcorrespondencepaper20050725.pdf | ||
| 25/07/2005 | SPC Documents | Annex SPC | 1 | /3/9/1/0/0/0400300193/docs/300193_23_supplprotectioncertificate20210203044403769.pdf | ||
| 26/04/2005 | Outgoing Correspondence | Outgoing Letter | 2 | /3/9/1/0/0/0400300193/docs/300193_3_outgoingcorrespondence20050426.pdf | ||
| 25/04/2005 | SPC Documents | Annex SPC | 2 | /3/9/1/0/0/0400300193/docs/300193_5_supplprotectioncertificate20210203043905318.pdf | ||
| 25/04/2005 | SPC Documents | Annex SPC | 62 | /3/9/1/0/0/0400300193/docs/300193_12_supplprotectioncertificate20210203043752482.pdf | ||
| 22/04/2005 | Outgoing Correspondence | Outgoing Letter | 1 | /3/9/1/0/0/0400300193/docs/300193_14_outgoingcorrespondence20050422.pdf | ||
| 20/04/2005 | SPC Documents | Marketing Authorization SPC | 4 | /3/9/1/0/0/0400300193/docs/300193_4_supplprotectioncertificate20210203043643065.pdf | ||
| 20/04/2005 | SPC Documents | Summary of the characteristics of the product | 16 | /3/9/1/0/0/0400300193/docs/300193_9_supplprotectioncertificate20210203035802121.pdf | ||
| 20/04/2005 | Application Form | First filed application form | 2 | /3/9/1/0/0/0400300193/docs/300193_18_applicationform20050420.pdf | ||
| 20/04/2005 | SPC Documents | Annex SPC | 2 | /3/9/1/0/0/0400300193/docs/300193_19_supplprotectioncertificate20210203035802221.pdf |